Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Advanced Chemotherapy Technologies, a US-based cancer drug delivery spinout of University of North Carolina at Chapel Hill, closed a $5.5m series A round yesterday led by venture capital firm Khosla Ventures. The funding will be used to drive initial clinical development of its technology, targeting certain forms of pancreatic cancer.
SurfactGreen, a France-based surfactant chemical producer, has secured €4.7m ($5.5m) of equity and grant funding from investors including regional tech transfer office Satt Ouest Valorisation. The total includes $1.9m of dilutive funding from Satt Ouest, Go Capital, Finovam Management and unnamed members of SurfactGreen’s team, in addition to $3.6m in subsidies from state-owned investment bank Bpifrance and the French Environment and Energy Management Agency. SurfactGreen produces surfactant materials using sustainable ingredients for applications including construction and cosmetics. Satt Ouest Valorisation backed a $1.3m round for SurfactGreen in 2017 together with the latter’s president Pierre-Yves Divet, Go Capital and seed fund Fira Nord-Est, according to Les Echos.
Medical device producer Nipro Corporation recently led a $5.3m seed round for Venari Medical, an Ireland-based spinout from National University of Ireland that is developing a catheter system to treat chronic venous disease, the startup announced on Wednesday. The corporate was joined by Western Development Commission, Enterprise Ireland and undisclosed angel investors, and the funding will support work on its device.
Business Market, a Japan-based deal matching platform developer, raised an undisclosed sum yesterday from Tokyo University of Science’s Investment Management Company and renewable energy and financial services firm Astmax Fund Management. Business Market will use the funding to expand its software and enter additional regional markets.